Beximco Pharmaceuticals Limited logo

Beximco Pharmaceuticals Limited (BXP)

Market Closed
2 Jan, 12:00 AM
£
42. 50
0
0%
£
- Market Cap
58.06 P/E Ratio
0.97% Div Yield
0 Volume
1.51 Eps
£ 42.5
Previous Close
Add Transaction
Day Range
42.5 42.5
Year Range
31.55 52.33
Want to track BXP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Beximco Pharmaceuticals Limited (BXP) Statistics

Valuation metrics

Market Cap -
Enterprise value 36.37B
Trailing P/E (ttm) 4.37
Forward P/E -
PEG ratio 0.16
Price/Sales (ttm) 0.7
Price/Book (mrq) 0.63
Enterprise Value/Revenue 0.68
Enterprise Value/EBITDA 2.87

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -

Price summary

52-Week low 31.55
52-Week high 52.33
Beta -
50-Day moving average -
200-Day moving average 42.5

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 3.78
Trailing annual dividend yield 0.045%
5-Year annual dividend yield -
Payout ratio 0.02
Dividend Date 6 Feb 2025
Ex-Dividend Date 22 Nov 2024
Last split factor 110:100
Last split Date 23 Nov 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.16%
Operating margin 0.21%

Operational effectiveness

Return on assets 0.11%
Return on equity 0.15%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 119.83
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 19.22
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 11.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 4.13%
Book value per share (mrq) 141.39

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -